Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis

BACKGROUND: The lipoprotein(a) pathway is a causal factor in coronary heart disease. We used a genetic approach to distinguish the relevance of two distinct components of this pathway, apolipoprotein(a) isoform size and circulating lipoprotein(a) concentration, to coronary heart disease. METHODS: In...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Diabetes Endocrinol
Main Authors: Saleheen, Danish, Haycock, Philip C, Zhao, Wei, Rasheed, Asif, Taleb, Adam, Imran, Atif, Abbas, Shahid, Majeed, Faisal, Akhtar, Saba, Qamar, Nadeem, Zaman, Khan Shah, Yaqoob, Zia, Saghir, Tahir, Rizvi, Syed Nadeem Hasan, Memon, Anis, Mallick, Nadeem Hayyat, Ishaq, Mohammad, Rasheed, Syed Zahed, Memon, Fazal-ur-Rehman, Mahmood, Khalid, Ahmed, Naveeduddin, Frossard, Philippe, Tsimikas, Sotirios, Witztum, Joseph L, Marcovina, Santica, Sandhu, Manjinder, Rader, Daniel J, Danesh, John
Formato: Artigo
Idioma:Inglês
Publicado em: The Lancet, Diabetes & Endocrinology 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5483508/
https://ncbi.nlm.nih.gov/pubmed/28408323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(17)30088-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados